Atopic-dermititis

Eczema (Atopic Dermatitis) Study

 

Eczema is the most common chronic relapsing, inflammatory skin disease affecting an estimated 35 million Americans. The disease profoundly impacts the quality of life for millions of people, affecting their social and leisure activities, work, school, and even their clothing choices.

The Study:

  • AMR Norfolk is now enrolling volunteers for a clinical research study evaluating an investigational medication for the treatment of moderate-to-severe eczema.

Qualified Participants:

  • Must be between the ages 18 to 70
  • Must be in general good health
  • Willing to complete up to 8 visits to the study center over a 16-week period

If Qualified and you participate you will receive:

  • All study-related medical exams, lab tests, and investigational medication or placebo. Compensation up to (TBD) is available for your time and travel.

Take the next step.  Call us at 757-627-6798 and ask for the Eczema enrollment team.  Better yet, fill out the brief contact form and we will call you!

×

Make an appointment and we’ll contact you.